Smith & Nephew plc ADR BDR logo

Smith & Nephew plc ADR BDR (S1NN34)

Market Closed
7 Aug, 19:55
B3 B3
R$
31. 62
0
0%
R$
71.91B Market Cap
39.73 P/E Ratio
1.83% Div Yield
0 Volume
0 Eps
R$ 31.62
Previous Close
Add Transaction
Day Range
31.62 31.62
Year Range
31.62 40.88
Want to track S1NN34 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

S1NN34 closed Friday higher at R$31.62, an increase of 0% from Thursday's close, completing a monthly decrease of -6.4774% or -R$2.19. Over the past 12 months, S1NN34 stock lost -11.7746%.
S1NN34 is not paying dividends to its shareholders.
The last earnings report, released on Feb 23, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

S1NN34 Chart

People also search for

BioNTech SE
R$ 29.64
-0.202%
BeiGene Ltd. ADR
R$ 69
+6.679%
Biogen Inc. Depositary Receipt
R$ 172
0%
Dexcom Inc. - BDR
R$ 8.98
+4.0556%
Alnylam Pharmaceuticals Inc.
R$ 55.38
-0.4315%

Smith & Nephew plc ADR BDR (S1NN34) FAQ

What is the stock price today?

The current price is R$31.62.

On which exchange is it traded?

Smith & Nephew plc ADR BDR is listed on B3.

What is its stock symbol?

The ticker symbol is S1NN34.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 1.83%.

What is its market cap?

As of today, the market cap is 71.91B.

Has Smith & Nephew plc ADR BDR ever had a stock split?

No, there has never been a stock split.

Smith & Nephew plc ADR BDR Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Deepak S. Nath CEO
B3 Exchange
- ISIN
GB Country
17,349 Employees
26 Mar 2026 Last Dividend
- Last Split
16 Nov 1999 IPO Date

Overview

Smith & Nephew plc is a renowned global medical technology company that has been developing, manufacturing, marketing, and selling medical devices and services since its founding in 1856. With a broad international presence, the company operates through three primary segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. These segments focus on delivering innovative solutions that improve patient outcomes in procedures ranging from knee and hip replacements to sports injuries and advanced wound care. Headquartered in Watford, the United Kingdom, Smith & Nephew plc has established itself as a leader in the medical devices sector, serving healthcare providers across the globe.

Products and Services

Smith & Nephew plc's diverse product portfolio is designed to address a wide range of medical needs, spanning orthopaedics, sports medicine and ENT (Ear, Nose, and Throat), and advanced wound management. Detailed descriptions of its products and services are as follows:

  • Knee Implant Products: These are designed for knee replacement procedures, helping patients regain mobility and reduce pain. They include a range of implants that cater to individual medical conditions and anatomical differences.
  • Hip Implants: Smith & Nephew provide hip implants for primary and revision procedures, designed to restore mobility and relieve hip pain caused by diseased or damaged hip joint conditions.
  • Trauma and Extremities Products: The company offers internal and external devices for the stabilization of severe fractures and deformity correction procedures. This range supports the accurate reconstruction of bones damaged by trauma or disease.
  • Sports Medicine Joint Repair: Smith & Nephew offers instruments, technologies, and implants for minimally invasive surgery to treat soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. This includes a focus on restoring function and preventing further injury to the affected areas.
  • Arthroscopic Enabling Technologies: This includes fluid management equipment, high-definition cameras, digital image capture, scopes, light sources, and monitors that aid in visualization inside the joints during surgical procedures. Additionally, radio frequency, electromechanical, and mechanical tissue resection devices, along with hand instruments, are provided for removing damaged tissue.
  • ENT Solutions: Smith & Nephew offers solutions for ear, nose, and throat surgeries and treatments, facilitating improved patient outcomes in these areas.
  • Advanced Wound Care: The company provides a comprehensive range of products for the treatment and prevention of acute and chronic wounds, including leg ulcers, diabetic foot ulcers, pressure ulcers, burns, and post-operative wounds. These are designed to promote healing, reduce complications, and improve the quality of life for patients with wound-related issues.
  • Advanced Wound Bioactives: Included are biologic and other bioactive technologies aimed at debridement, dermal repair, and regeneration. These products support the natural healing processes, enhancing the body's ability to heal itself.
  • Regenerative Medicine Products: This category features skin, bone graft, and articular cartilage substitutes, which are vital in treatments that require the regeneration of tissues.
  • Advanced Wound Devices: Smith & Nephew also offers both traditional and single-use negative pressure wound therapy systems and hydrosurgery systems, which are innovative solutions designed to aid in the management and healing of complex wounds.

Contact Information

Address: Building 5
Phone: 44 1923 477 100